Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many patients considering GLP-1 weight loss therapy also use testosterone replacement therapy (TRT), raising important safety questions. While semaglutide and testosterone operate through different biological pathways, their combined use requires informed medical guidance and proper monitoring to ensure safe and effective outcomes.
How Testosterone and Semaglutide Work in Your Body
Testosterone is an androgenic hormone that influences muscle growth, bone density, metabolic rate, and sexual function. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, reduces appetite by signaling fullness to the brain and slowing stomach emptying. These two compounds target fundamentally different biological systems: testosterone affects androgen receptors throughout the body, while semaglutide primarily engages GLP-1 pathways in the hypothalamus and gastrointestinal tract.
When you combine these therapies, they do not directly interfere with each other's receptor mechanisms. However, both influence body composition and metabolic function, meaning their combined effect on weight loss, muscle retention, and energy expenditure requires careful coordination with your prescribing physician. Understanding each agent's role helps explain why medical supervision matters when using both simultaneously.
Drug Interaction Risks Between Testosterone and GLP-1 Medications
Clinical data show no major direct pharmacokinetic interactions between testosterone and semaglutide or other GLP-1 agonists. Both compounds are processed through different metabolic pathways—testosterone via hepatic metabolism and protein binding, semaglutide via peptidase breakdown and renal clearance—reducing the risk of one agent blocking or accelerating the other's clearance. Existing safety databases and pharmacological reviews do not flag a contraindication to combined use.
The more clinically relevant concern involves indirect effects on metabolism and cardiovascular health. Testosterone can increase hemoglobin and blood viscosity, while GLP-1 medications may lower blood pressure and improve cardiovascular markers. When combined, these effects require baseline and periodic monitoring including lipid panels, glucose tolerance, blood pressure, and hematocrit levels. Your healthcare provider should assess your individual cardiovascular risk before starting both therapies together.
Medical Supervision and Monitoring Guidelines
If you are taking testosterone and wish to start semaglutide or another GLP-1 therapy, inform your prescribing physician of your complete medication and supplement list. A baseline physical exam and lab work—including testosterone levels, hemoglobin, lipid panel, fasting glucose, and liver/kidney function—establish a safety reference point. Your doctor may recommend staggered initiation, starting with a low semaglutide dose while maintaining stable testosterone dosing, allowing your body to adapt to the GLP-1 effect.
Ongoing monitoring should include follow-up labs every 4–8 weeks during the initial phase of semaglutide therapy, then every 3–6 months once your dose stabilizes. Report any new chest discomfort, shortness of breath, sudden weight loss beyond expectations, mood changes, or signs of polycythemia (headaches, dizziness, flushed skin) to your provider immediately. This vigilance ensures that the combination remains safe and effective for your unique health profile.
Why Personalized Peptide Testing Matters for Dual Therapies
PlexusDx offers the Precision Peptide Genetic Test, which analyzes how your genetic variants in key metabolic pathways influence your response to GLP-1 compounds and hormone therapy. The test examines 14 different peptide pathways and 150+ genetic insights, including variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) that directly affect appetite regulation, weight loss response, and metabolic efficiency. Understanding your genetic predispositions helps your physician select the optimal GLP-1 formulation and dosing strategy while you are on testosterone.
When combining testosterone and GLP-1 therapy, genetic insights can reveal whether your body may struggle with lean muscle retention during rapid weight loss, or conversely, whether you are genetically inclined to preserve muscle while losing fat. This personalization allows your care team to adjust your testosterone dose or choose a GLP-1 compound that aligns with your genetic metabolic profile, reducing side effect risk and improving outcomes. PlexusDx's Precision Peptide Genetic Test is available as a $99 add-on after your first month of semaglutide treatment, helping you unlock precision medicine benefits.
Choosing the Right GLP-1 Therapy Alongside Testosterone
PlexusDx offers compounded semaglutide injections starting at $149 per month, oral semaglutide at $249 per month, and tirzepatide options for those seeking dual GLP-1/GIP receptor activation. Your dose may need to go up—your price won't. Each formulation is prepared by licensed 503A compounding pharmacies and is available across all 50 states without requiring insurance or membership fees. If you are on testosterone, your healthcare provider can prescribe any of these options based on your tolerability, previous medication responses, and clinical goals.
The choice between injection and oral forms often depends on personal preference and consistency. Injections typically offer once-weekly dosing for semaglutide, improving adherence, while oral forms provide daily flexibility. Both are HSA/FSA eligible, making them accessible options for many patients. Discuss with your provider whether your testosterone regimen might benefit from dose adjustments as your weight and appetite change on GLP-1 therapy, ensuring hormone replacement remains appropriate throughout your weight loss journey.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I safely take testosterone replacement therapy while using semaglutide?
Yes, when properly supervised by your physician. Testosterone and semaglutide do not have major direct drug interactions. However, both affect metabolism and cardiovascular function, so baseline and periodic labs—including testosterone levels, hemoglobin, lipids, and blood pressure—are essential. Inform your doctor of both medications before starting either one.
Will semaglutide lower my testosterone levels?
Semaglutide does not directly suppress testosterone production. However, rapid weight loss itself can temporarily affect hormone levels in some individuals. If you are concerned about testosterone stability while on GLP-1 therapy, work with your endocrinologist or primary care physician to monitor levels every 4–8 weeks during initial semaglutide therapy and adjust your testosterone dose if needed.
What is PlexusDx Precision Peptide Genetic Testing and how does it help with combined therapies?
PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month of treatment) analyzes 14 peptide pathways and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R. This test reveals how your unique genetics influence GLP-1 response and metabolic efficiency, helping your physician optimize your semaglutide dose and testosterone management for better outcomes and fewer side effects.
What are the most important safety monitoring steps when combining testosterone and GLP-1?
Get baseline labs including hemoglobin, lipid panel, fasting glucose, liver/kidney function, and blood pressure before starting. Follow up every 4–8 weeks initially, then every 3–6 months once stable. Report any chest discomfort, shortness of breath, unusual dizziness, or signs of high blood viscosity to your provider immediately. Maintain open communication with both your hormone replacement and GLP-1 prescribers.
Does PlexusDx offer affordable GLP-1 options that work well with testosterone therapy?
Yes. PlexusDx's compounded semaglutide injection starts at $149 per month (from licensed 503A pharmacies), with oral semaglutide at $249 per month. Your dose may need to go up—your price won't. All formulations are available in all 50 states, no insurance required, and are HSA/FSA eligible. Your provider can select the best option for your testosterone regimen and health goals.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Your Ozempic Pen: What to Expect and How It Comes
Is Insurance Covering Ozempic for Weight Loss?